Patent details

EP2316473 Title: Use of calcitonin in osteoarthritis

Basic Information

Publication number:
EP2316473
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101777514
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of calcitonin in osteoarthritis
French Title of Invention:
Utilisation de la calcitonine pour le traitement de la arthrose
German Title of Invention:
Verwendung von Calcitonin zur Behandlung von Osteoarthritis
SPC Number:

Dates

Filing date:
22/07/2004
Grant date:
21/08/2013
EP Publication Date:
21/08/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/05/2011
EP B1 Publication Date:
21/08/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/07/2014
Expiration date:
22/07/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/07/2004
 
 

Name:
Nordic Bioscience A/S
Address:
Herlev Hovedgade 207, 2730 Herlev, Denmark (DK)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
Christiansen Claus
Address:
Denmark (DK)

2

Name:
Bateman Simon David
Address:
United States (US)

3

Name:
Azria Moise
Address:
Switzerland (CH)

4

Name:
Li Shoufeng
Address:
United States (US)

Priority

Priority Number:
489400 P
Priority Date:
23/07/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/23;
Filing date Document type Number of pages